The Department of Biomedical Sciences manages the research activity in Biology, Medicine and Public Health. It provides technologies and services to both the public and the private area, with the purpose of promoting knowledge on the fundamental mechanism governing physiological and pathological aspects in living organism, starting from basic research in life sciences to the study of human diseases and of innovative therapeutic interventions. The ultimate aim is to explore new opportunities for ameliorating the health of mankind.
The fundamental activities regard oncology, neurodegenerative diseases, cardiovascular and pulmonary diseases, immunology and infectious diseases, epidemiology and health care research, Biology and biomedical technologies. In these areas, some technologies have been developed and they have found a wider use in the different benchmark areas: proteomics, pharmacogenomics, advanced calculus in bioinformatics and system biology, robotic systems for the limbs’ rehabilitation, molecular diagnostics and imaging.
A recent study published in the high impact journal Acta Neuropathologica, coordinated by Claudia Verderio of the Cnr Institute of Neuroscience and involving, among other institutions shows that microglia is always beneficial towards oligodendrocytes but become detrimental through the activation of astrocytes, the most abundant glial cell type in the brain
The Nanomedicine School is dedicated to Master students, PhD students, early stage researchers, and whoever is interested in an introduction to this rather new field of research. The scientific programme includes the following topics: Nanodrugs, Materials for Nanomedicine, From bench to bed, Nanodevices
The World Health Organization has designated the Neuroscience Institute as a WHO Collaborating Centre
The World Health Organization (WHO) has designated the Cnr Institute of Neuroscience (Cnr-In) as a WHO Collaborating Center for 'Longitudinal Health and Cross-Country Statistical modelling' and Nadia Minicuci (Cnr-In) will act as Head of the Centre
On the first of January 2019, the European project SensApp (Super-sensitive detection of Alzheimer's disease biomarkers in plasma by an innovative droplet and split-stack approach) officially started, with the aim of developing a super-sensor for the early diagnosis of the Alzheimer's disease by a simple blood test
The Director of the International Mixed Unit between Cnr and University Laval for ‘chemical and biomolecular research on microbiome and its impact on metabolic health and nutrition’, Vincenzo Di Marzo, of the Cnr-Icb, and the delegate of the President of the Cnr in the UMI Steering Committee, Emanuele Fiore, of the Ipcb-Cnr, met on june 27th in Ottawa with the Ambassador of Italy to Canada, H.E. Claudio Taffuri, and the President and CEO of the Canada Foundation for Innovation, Roseanne O'Reilly Runte
The 2nd Ancel Keys International Seminar on Mediterranean diet and sustainable nutritional policies is intended to provide a contribution to this important goal by giving start to a high-level teaching action
Cnr-Isa is amongst the research partners of 'Stance4Health', a project funded by European Union’s Horizon 2020 with tha aim of developing a complete Smart Personalized Nutrition (SPN) service based on the use of mobile technologies as well as tailored food production that will optimize the gut microbiota activity and long-term consumer engagement